AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Glimnib MP1 Tablet PR

Prescription Icon
Prescription Required

Marketer

San-Pen Pharmaceuticals Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Glimnib MP1 Tablet PR

Glimepiride-Metformin combination tablets (MP1) effectively manage blood glucose in adults with type 2 diabetes. This medication, used alongside a healthy diet and exercise program, enhances insulin efficacy, thus reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen; take it with food to minimize stomach discomfort. Missed doses should be taken promptly unless the next dose is imminent; avoid doubling doses to prevent hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Patients with kidney, liver, or heart conditions, as well as pregnant or breastfeeding individuals, must consult their doctor before initiating treatment. Kidney function will be assessed prior to commencing therapy. Limiting alcohol consumption is advised to mitigate potential side effects.

Uses of Glimnib MP1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimnib MP1 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Take Glimnib MP1 Tablet PR with meals.

Common Side effects of Glimnib MP1 Tablet PR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glimnib MP1 Tablet PR:

Follow your doctor's instructions or consult the product label for guidance. Take Glimnib MP1 Tablet PR with a meal.

How Glimnib MP1 Tablet PR works:

Glimnib MP1 Tablet PR unites three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. These medications employ diverse mechanisms to optimize blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimnib MP1 Tablet PR with alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimnib MP1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers before recommending its use. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Glimnib MP1 Tablet PR while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimnib MP1 Tablet PR to individuals with kidney impairment; dosage modification may be necessary. Consult a physician. Glimnib MP1 Tablet PR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Glimnib MP1 Tablet PR, as dosage modification may be necessary. Consult a physician before use. Glimnib MP1 Tablet PR is contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Glimnib MP1 Tablet PR :

Should you forget a Glimnib MP1 Tablet PR dose, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimnib MP1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimnib MP1 Tablet PR

Drinking alcohol while taking Glimnib MP1 Tablet PR is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Consult your doctor before taking Glimnib MP1 Tablet PR if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
Metformin, a component of Glimnib MP1 Tablet PR, can lead to vitamin B12 deficiency with prolonged use due to impaired stomach absorption of this vitamin.
Glimnib MP1 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always keep a quick-acting sugar source, such as candy or chocolate, on hand.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimnib MP1 Tablet PR
122
MRP 149
18% off